COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,760 Articles (22,502 medRxiv, 8,258 bioRxiv)

Most recent first Previous |  Page 531: Articles 5301-5310  | Next

Changes in Alcohol Consumption during the COVID-19 Pandemic: Evidence from Wisconsin
Pomazal, R., McCulley, L., Schultz, A., Stafford, N., Schowalter, M., Malecki, K.
10.1101/2022.11.07.22282029 — Posted: 2022-11-07
Systematic review of the prevalence of Long Covid
Woodrow, M. C., Carey, C., Ziauddeen, N., Thomas, R., Akrami, A., Lutje, V., Greenwood, D. C., Alwan, N. A.
10.1101/2022.11.06.22281979 — Posted: 2022-11-07
Systematic review of the clinical effectiveness of Tixagevimab/Cilgavimab for prophylaxis of COVID-19 in immunocompromised patients
Suribhatla, R., Starkey, T., Ionescu, M. C., Pagliuca, A., Richter, A., Lee, L. Y.
10.1101/2022.11.07.22281786 — Posted: 2022-11-07
A comprehensive knowledgebase of known and predicted human genetic variants associated with COVID-19 susceptibility and severity
Kars, M. E., Stein, D., Sevim Bayrak, C., Stenson, P. D., Cooper, D. N., Itan, Y.
10.1101/2022.11.03.22281867 — Posted: 2022-11-07
Stress, coping, and quality of life in the United States during the COVID-19 pandemic
Wakeel, F., Hannah, J., Gorfinkel, L.
10.1101/2022.11.03.22281899 — Posted: 2022-11-07
Mathematical Modeling of Impacts of Patient Differences on COVID-19 Lung Fibrosis Outcomes
Islam, M. A., Ford Versypt, A. N.
10.1101/2022.11.06.515367 — Posted: 2022-11-07
Temporal Vascular Endothelial Growth Factor Sub-type gene Switching in SARS-CoV Pathogenesis. Interpretation through in vivo Murine C57BL Models
Rashid, A., Malik, Z. A., Sharma, V., Sharma, A., Gupta, L., Alkhazaimi, H., Shaikh, G., Al-Dubai, A., Hussain, A.
10.1101/2022.11.06.515327 — Posted: 2022-11-07
Novel inhibitors against COVID-19 main protease suppressed viral infection
Ramachandran, V., Liu, Y., He, Q., Tang, A., Ronaldson, P., Schenten, D., Chang, R.
10.1101/2022.11.05.515305 — Posted: 2022-11-07
Pharmacological modulators of epithelial immunity uncovered by synthetic genetic tracing of SARS-CoV-2 infection responses
Jiang, B., Schmitt, M. J., Rand, U., Company, C., Grossmann, M., Serresi, M., Cicin-Sain, L., Gargiulo, G.
10.1101/2022.11.05.515197 — Posted: 2022-11-07
Wildlife exposure to SARS-CoV-2 across a human use gradient
Goldberg, A. R., Langwig, K. E., Marano, J. M., Sharp, A. K., Brown, K. L., Ceci, A., Kailing, M. J., Briggs, R., Roby, C., Brown, A. M., Weger-Lucarelli, J., Finkielstein, C. v., Hoyt, J. R.
10.1101/2022.11.04.515237 — Posted: 2022-11-07

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).